AntiCancer regulatory update

AntiCancer received U.S. Patent No. 5,474,909 covering its histoculture drug response assay (HDRA), which enables physicians to select the optimum chemotherapy treatment for an individual. A portion of the patient's tumor, taken during initial surgery or biopsy, is grown in a test tube at AntiCancer's San Diego Laboratory. The sample then is treated in vitro with the possible chemotherapeutic drugs. Scientists analyze the growth patterns of the tumor and the results are faxed to the oncologist. The process takes 72 hours. ...